A lot of studies done in the past three decades helped a lot in understanding the molecular mechanisms associated with Ischemia-reperfusion<unk> . Also, these studies helped in evaluating various strategies to decrease the incidence and severity associated with Ischemia-reperfusion<unk> . 
Existing therapies for Ischemia-reperfusion<unk>  can be divided into Pharmacological and non-pharmacological interventions. A lot of promising studies and clinical trials are still under the pipeline. Till the date, the most encouraging results are associated with ischemic preconditioning and postconditioning, adenosine, and exenatide. A lot of studies have demonstrated the combined effect of pharmacological and nonpharmacological approach as together to be used as a multifactorial approach to improve the clinical outcomes.
Reperfusion injury future or investigational therapies
Appropriate use criteria for revascularization
Sudden cardiac death post arrest care and prevention
Tumor lysis syndrome cost-effectiveness of therapy
Deep vein thrombosis future or investigational therapies
Sudden cardiac death definitions and diagnosis
Cirrhosis future or investigational therapies
Deep vein thrombosis landmark trials in treatment